-
1
-
-
0034105129
-
Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7
-
Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161(5): 1501-1507. (Pubitemid 30329018)
-
(2000)
American Journal of Respiratory and Critical Care Medicine
, vol.161
, Issue.5
, pp. 1501-1507
-
-
Sigurs, N.1
Bjarnason, R.2
Sigurbergsson, F.3
Kjellman, B.4
-
2
-
-
12144272208
-
Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13
-
DOI 10.1164/rccm.200406-730OC
-
Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137-141. (Pubitemid 40105412)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.171
, Issue.2
, pp. 137-141
-
-
Sigurs, N.1
Gustafsson, P.M.2
Bjarnason, R.3
Lundberg, F.4
Schmidt, S.5
Sigurbergsson, F.6
Kjellman, B.7
-
3
-
-
77958471150
-
Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life
-
Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045-1052.
-
(2010)
Thorax
, vol.65
, Issue.12
, pp. 1045-1052
-
-
Sigurs, N.1
Aljassim, F.2
Kjellman, B.3
-
4
-
-
0033554244
-
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
-
DOI 10.1016/S0140-6736(98)10321-5
-
Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541-545. (Pubitemid 29381367)
-
(1999)
Lancet
, vol.354
, Issue.9178
, pp. 541-545
-
-
Stein, R.T.1
Sherrill, D.2
Morgan, W.J.3
Holberg, C.J.4
Halonen, M.5
Taussig, L.M.6
Wright, A.L.7
Martinez, F.D.8
-
5
-
-
2942692108
-
Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection
-
DOI 10.1136/thx.2003.013391
-
Bont L, Steijn M, Van Aalderen WM, et al. Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax. 2004;59 (6):512-516. (Pubitemid 38797525)
-
(2004)
Thorax
, vol.59
, Issue.6
, pp. 512-516
-
-
Bont, L.1
Steijn, M.2
Van Aalderen, W.M.C.3
Brus, F.4
Draaisma, J.M.Th.5
Van Diemen-Steenvoorde, R.A.A.M.6
Pekelharing-Berghuis, M.7
Kimpen, J.L.L.8
-
6
-
-
23944438854
-
Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study
-
DOI 10.1111/j.1399-3038.2005.00298.x
-
Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study. Pediatr Allergy Immunol. 2005; 16(5):386-392. (Pubitemid 41207478)
-
(2005)
Pediatric Allergy and Immunology
, vol.16
, Issue.5
, pp. 386-392
-
-
Henderson, J.1
Hilliard, T.N.2
Sherriff, A.3
Stalker, D.4
Al Shammari, N.5
Thomas, H.M.6
-
7
-
-
79951846201
-
Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants
-
Romero JR, Stewart DL, Buysman EK, Fernandes AW, Jafri HS, Mahadevia PJ. Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants. Clin Ther. 2010;32(14):2422-2432.
-
(2010)
Clin Ther
, vol.32
, Issue.14
, pp. 2422-2432
-
-
Romero, J.R.1
Stewart, D.L.2
Buysman, E.K.3
Fernandes, A.W.4
Jafri, H.S.5
Mahadevia, P.J.6
-
8
-
-
16944363559
-
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus
-
Johnson S, Oliver C, Prince GA, et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis. 1997;176(5):1215-1224. (Pubitemid 27460986)
-
(1997)
Journal of Infectious Diseases
, vol.176
, Issue.5
, pp. 1215-1224
-
-
Johnson, S.1
Oliver, C.2
Prince, G.A.3
Hemming, V.G.4
Pfarr, D.S.5
Wang, S.-C.6
Dormitzcr, M.7
O'Grady, J.8
Koenig, S.9
Tamura, J.K.10
Woods, R.11
Bansal, G.12
Couchenour, D.13
Tsao, E.14
Hall, W.C.15
Young, J.F.16
-
9
-
-
0031683919
-
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
-
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3 pt 1):531- 537.
-
(1998)
Pediatrics
, vol.102
, Issue.3 PART 1
, pp. 531-537
-
-
-
10
-
-
34250635926
-
Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing
-
Simoes EA, Groothuis JR, Carbonell- Estrany X, et al Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007;151(1): 34-42.
-
(2007)
J Pediatr
, vol.151
, Issue.1
, pp. 34-42
-
-
Simoes, E.A.1
Groothuis, J.R.2
Carbonell-, E.X.3
-
11
-
-
77955926764
-
The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children
-
Palivizumab Long-Term Respiratory Outcomes Study Group
-
Simões EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR; Palivizumab Long-Term Respiratory Outcomes Study Group. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol. 2010;126(2):256-262.
-
(2010)
J Allergy Clin Immunol
, vol.126
, Issue.2
, pp. 256-262
-
-
Simões, E.A.1
Carbonell-Estrany, X.2
Rieger, C.H.3
Mitchell, I.4
Fredrick, L.5
Groothuis, J.R.6
|